An Open-Label Extension of the Study XEN496 (Ezogabine) in Children With KCNQ2-DEE
Clinical trial NCT04912856 · TERMINATED
Trial details
- NCT number
- NCT04912856
- Sponsor
- Xenon Pharmaceuticals Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-17
- Primary completion
- 2023-11-17
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.